HopeStage
Back to all studies
Enrolling By InvitationNCT06736769

Ketamine Effects on Learning In Eating disorders

Medication studyAges 16–26United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 26 years.

Listed locations
San FranciscoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 5, 2025
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
20
Sponsor
Amanda Downey, MD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 16 Years to 26 Years
Official registry ID
NCT06736769
Official title
Show the full official title

"KETTLE" Trial: Ketamine Effects on Learning In Eating Disorders

Recruitment & locations

By invitation

San Francisco

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Amanda Downey, MD.

Does this study involve medication?

Yes. The study involves medication, including Ketamine infusion.

Who can participate?

Listed age limits: 16 years to 26 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies